Vertebral fractures are increased in rheumatoid arthritis despite recent therapeutic advances: a case-control study.
Osteoporosis
Rheumatoid arthritis
Vertebral fractures
Journal
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
ISSN: 1433-2965
Titre abrégé: Osteoporos Int
Pays: England
ID NLM: 9100105
Informations de publication
Date de publication:
Jul 2021
Jul 2021
Historique:
received:
23
09
2020
accepted:
04
01
2021
pubmed:
19
1
2021
medline:
16
6
2021
entrez:
18
1
2021
Statut:
ppublish
Résumé
Prevalence and risk factors of vertebral fractures in postmenopausal RA women were assessed in 323 patients and compared with 660 age-matched women. Of patients, 24.15% had at least one vertebral fracture vs.16.06% of controls. Age, glucocorticoids and falls were the main fracture risks. Vertebral fractures were associated with disease severity. There is little quality data on the updated prevalence of fractures in rheumatoid arthritis (RA) that may have changed due to advances in the therapeutic strategy in recent years. This study was aimed at analysing the prevalence and risk factors of vertebral fractures in postmenopausal women with RA and comparing it with that of the general population. We included 323 postmenopausal women diagnosed with RA from 19 Spanish Rheumatology Departments, randomly selected and recruited in 2018. Lateral radiographs of the thoracic and lumbar spine were obtained to evaluate morphometric vertebral fractures and the spinal deformity index. We analysed subject characteristics, factors related to RA, and fracture risk factors. The control group consisted of 660 age-matched Spanish postmenopausal women from the population-based Camargo cohort. Seventy-eight (24.15%) RA patients had at least one vertebral fracture. RA patients had increased fracture risk compared with controls (106 of 660, 16.06%) (p = 0.02). Logistic regression analysis showed that age (OR 2.17; 95% CI 1.27-4.00), glucocorticoids (OR 3.83; 95% CI 1.32-14.09) and falls (OR 3.57; 95% CI 1.91-6.86) were the independent predictors of vertebral fractures in RA patients. The subgroup with vertebral fractures had higher disease activity (DAS28: 3.15 vs. 2.78, p = 0.038) and disability (HAQ: 0.96 vs. 0.63, p = 0.049), as compared with those without vertebral fractures. The risk of vertebral fracture in RA is still high in recent years, when compared with the general population. The key determinants of fracture risk are age, glucocorticoids and falls. Patients with vertebral fractures have a more severe RA.
Identifiants
pubmed: 33459805
doi: 10.1007/s00198-021-05824-7
pii: 10.1007/s00198-021-05824-7
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1333-1342Subventions
Organisme : Instituto de Salud Carlos III
ID : PI18/00762
Références
Amin S, Gabriel SE, Achenbach SJ, Atkinson EJ, Melton LJ 3rd. (2013) Are young women and men with rheumatoid arthritis at risk for fragility fractures? A population-based study. J Rheumatol 40(10):1669–1676
pubmed: 23950189
pmcid: 3910326
Kim SY, Schneeweiss S, Liu J, Daniel GW, Chang CL, Garneau K et al (2010) Risk of osteoporotic fracture in a large population-based cohort of patients with rheumatoid arthritis. Arthritis Res Ther 12(4):R154
pubmed: 20682035
pmcid: 2945054
van Staa TP, Geusens P, Bijlsma JW, Leufkens HG, Cooper C (2006) Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum 54(10):3104–3112
pubmed: 17009229
Xue AL, Wu SY, Jiang L, Feng AM, Guo HF, Zhao P (2017) Bone fracture risk in patients with rheumatoid arthritis: a meta-analysis. Medicine (Baltimore) 96(36):e6983
Tong JJ, Xu SQ, Zong HX, Pan MJ, Teng YZ, Xu JH (2020) Prevalence and risk factors associated with vertebral osteoporotic fractures in patients with rheumatoid arthritis [published correction appears in Clin Rheumatol. 2020 Jun;39(6):2023]. Clin Rheumatol 39(2):357–364
pubmed: 31691041
Buehring B, Thomas J, Wittkämper T, Baraliakos X, Braun J (2020) Evaluation of the trabecular bone score (TBS) in routine clinical care of patients with inflammatory rheumatic and non-inflammatory diseases: correlation with conventional bone mineral density measurement and prevalence of vertebral fractures. Z Rheumatol. https://doi.org/10.1007/s00393-020-00764-9
Dubrovsky AM, Lim MJ, Lane NE (2018) Osteoporosis in rheumatic diseases: anti-rheumatic drugs and the skeleton. Calcif Tissue Int 102(5):607–618
pubmed: 29470611
Ricciardi BF, Paul J, Kim A, Russell LA, Lane JM (2013) Osteoporosis drug therapy strategies in the setting of disease-modifying agents for autoimmune disease. Osteoporos Int 24(2):423–432
pubmed: 22955310
Briot K, Rouanet S, Schaeverbeke T, Etchepare F, Gaudin P, Perdriger A et al (2015) The effect of tocilizumab on bone mineral density, serum levels of Dickkopf-1 and bone remodeling markers in patients with rheumatoid arthritis. Joint Bone Spine 82(2):109–115
pubmed: 25557658
Hauser B, Riches PL, Wilson JF, Horne AE, Ralston SH (2014) Prevalence and clinical prediction of osteoporosis in a contemporary cohort of patients with rheumatoid arthritis. Rheumatology (Oxford) 53(10):1759–1766
Siu S, Haraoui B, Bissonnette R, Bessette L, Roubille C, Richer V et al (2015) Meta-analysis of tumor necrosis factor inhibitors and glucocorticoids on bone density in rheumatoid arthritis and ankylosing spondylitis trials. Arthritis Care Res (Hoboken). 67(6):754–764
pubmed: 25418272
Kawai VK, Grijalva CG, Arbogast PG, Curtis JR, Solomon DH, Delzell E et al (2013) Initiation of tumor necrosis factor α antagonists and risk of fractures in patients with selected rheumatic and autoimmune diseases. Arthritis Care Res (Hoboken) 65(7):1085–1094
Ozen G, Pedro S, Wolfe F, Michaud K (2019) Medications associated with fracture risk in patients with rheumatoid arthritis. Ann Rheum Dis 78(8):1041–1047
pubmed: 31092411
Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd et al (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative [published correction appears in Ann Rheum Dis. 2010 Oct;69(10):1892]. Ann Rheum Dis 69(9):1580–1588
pubmed: 20699241
Martínez J, Olmos JM, Hernández JL, Pinedo G, Llorca J, Obregón E et al (2009) Bone turnover markers in Spanish postmenopausal women: the Camargo cohort study. Clin Chim Acta 409(1-2):70–74
pubmed: 19737549
Olmos JM, Hernández JL, García-Velasco P, Martínez J, Llorca J, González-Macías J (2016) Serum 25-hydroxyvitamin D, parathyroid hormone, calcium intake, and bone mineral density in Spanish adults. Osteoporos Int 27(1):105–113
pubmed: 26134682
Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8(9):1137–1148
pubmed: 8237484
Kerkeni S, Kolta S, Fechtenbaum J, Roux C (2009) Spinal deformity index (SDI) is a good predictor of incident vertebral fractures. Osteoporos Int 20(9):1547–1552
pubmed: 19137350
Kanis JA (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int 4(6):368–381
pubmed: 7696835
Zerbini CAF, Clark P, Mendez-Sanchez L, Pereira RMR, Messina OD, Uña CR et al (2017) Biologic therapies and bone loss in rheumatoid arthritis. Osteoporos Int 28(2):429–446
pubmed: 27796445
Lin YC, Li YH, Chang CH, Hu CC, Chen DW, Hsieh PH et al (2015) Rheumatoid arthritis patients with hip fracture: a nationwide study. Osteoporos Int 26(2):811–817. https://doi.org/10.1007/s00198-014-2968-y
doi: 10.1007/s00198-014-2968-y
pubmed: 25410437
Nyhäll-Wåhlin BM, Ajeganova S, Petersson IF, Andersson M (2019) Increased risk of osteoporotic fractures in Swedish patients with rheumatoid arthritis despite early treatment with potent disease-modifying anti-rheumatic drugs: a prospective general population-matched cohort study. Scand J Rheumatol 48(6):431–438
pubmed: 31322028
Mazzucchelli R, Pérez Fernandez E, Crespí-Villarías N, Quirós-Donate J, García Vadillo A, Espinosa M et al (2018) Trends in hip fracture in patients with rheumatoid arthritis: results from the Spanish National Inpatient Registry over a 17-year period (1999-2015). TREND-AR study. RMD Open 4(1):e000671
pubmed: 29955384
pmcid: 6018884
Mazzucchelli R, Pérez Fernández E, Crespí Villarías N, Tejedor Alonso MÁ, Sáez López P et al (2019) East-west gradient in hip fracture incidence in Spain: how much can we explain by following the pattern of risk factors? Arch Osteoporos 14(1):115
pubmed: 31773387
Pueyo-Sánchez MJ, Larrosa M, Suris X, Casado E, Auleda J, Fusté J et al (2017) Secular trend in the incidence of hip fracture in Catalonia, Spain, 2003-2014. Age Ageing 46(2):324–328
pubmed: 27810855
Soukola SK, Jämsen ERK, Pauniaho SLK, Ukkonen MT (2020) A population-based study of 2347 fall-related injuries among older people in a Finnish emergency department. Eur Geriatr Med 11(2):315–320
pubmed: 32297195
Armstrong C, Swarbrick CM, Pye SR, O'Neill TW (2005) Occurrence and risk factors for falls in rheumatoid arthritis. Ann Rheum Dis 64(11):1602–1604
pubmed: 15817660
pmcid: 1755283
Clynes MA, Jameson K, Prieto-Alhambra D, Harvey NC, Cooper C, Dennison EM (2019) Impact of rheumatoid arthritis and its management on falls, fracture and bone mineral density in UK Biobank. Front Endocrinol (Lausanne) 10:817
Vis M, Havaardsholm EA, Haugeberg G, Uhlig T, Voskuyl AE, van de Stadt RJ et al (2006) Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFkappaB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis. Ann Rheum Dis 65(11):1495–1499
pubmed: 16606653
pmcid: 1798341
Stemmler F, Simon D, Liphardt AM, Englbrecht M, Rech J, Hueber AJ et al (2018) Biomechanical properties of bone are impaired in patients with ACPA-positive rheumatoid arthritis and associated with the occurrence of fractures. Ann Rheum Dis 77(7):973–980
pubmed: 29475856
pmcid: 6029639
Bugatti S, Bogliolo L, Vitolo B, Manzo A, Montecucco C, Caporali R (2016) Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis. Arthritis Res Ther 18(1):226
pubmed: 27716332
pmcid: 5052789
Kim D, Cho SK, Park B, Jang EJ, Bae SC, Sung YK (2018) Glucocorticoids are associated with an increased risk for vertebral fracture in patients with rheumatoid arthritis. J Rheumatol 45(5):612–620
pubmed: 29545455
Wang Y, Zhao R, Gu Z, Dong C, Guo G, Li L (2020) Effects of glucocorticoids on osteoporosis in rheumatoid arthritis: a systematic review and meta-analysis. Osteoporos Int 31(8):1401–1409
pubmed: 32291467
Ibañez M, Ortiz AM, Castrejón I, Garcia-Vadillo JA, Carvajal I, Castañeda S et al (2010) A rational use of glucocorticoids in patients with early arthritis has a minimal impact on bone mass. Arthritis Res Ther 12(2):R50
pubmed: 20331862
pmcid: 2888199
Sambrook PN, Cohen ML, Eisman JA, Pocock NA, Champion GD, Yeates MG (1989) Effects of low dose corticosteroids on bone mass in rheumatoid arthritis: a longitudinal study. Ann Rheum Dis 48(7):535–538
pubmed: 2774695
pmcid: 1003811
Habib GS, Haj S (2005) Bone mineral density in patients with early rheumatoid arthritis treated with corticosteroids. Clin Rheumatol 24(2):129–133
pubmed: 15372317
Güler-Yüksel M, Hoes JN, Bultink IEM, Lems WF (2018) Glucocorticoids, inflammation and bone. Calcif Tissue Int 102(5):592–606
pubmed: 29313071
Blavnsfeldt AG, de Thurah A, Thomsen MD, Tarp S, Langdahl B, Hauge EM (2018) The effect of glucocorticoids on bone mineral density in patients with rheumatoid arthritis: a systematic review and meta-analysis of randomized, controlled trials. Bone. 114:172–180
pubmed: 29913256
Peel NF, Moore DJ, Barrington NA, Bax DE, Eastell R (1995) Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis. Ann Rheum Dis 54(10):801–806
pubmed: 7492217
pmcid: 1010013
Luengo M, Picado C, Del Rio L, Guañabens N, Montserrat JM, Setoain J (1991) Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study. Thorax 46(11):803–806
pubmed: 1771602
pmcid: 1021033
van Staa TP, Laan R, Barton IP, Cohen V, Reid DM, Cooper C (2003) Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum 48(11):3224–3229
pubmed: 14613287
Kanis JA, Johansson H, Oden A, Johnell O, de Laet C, Melton C III et al (2004) A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 19(6):893–899
pubmed: 15125788
Compston J (2018) Glucocorticoid-induced osteoporosis: an update. Endocrine. 61(1):7–16
pubmed: 29691807
pmcid: 5997116
Choi YJ, Chung YS, Suh CH, Jung JY, Kim HA (2017) Trabecular bone score as a supplementary tool for the discrimination of osteoporotic fractures in postmenopausal women with rheumatoid arthritis. Medicine (Baltimore) 96(45):e8661
Florez H, Hernández-Rodríguez J, Muxi A, Carrasco JL, Prieto-González S, Cid MC et al (2020) Trabecular bone score improves fracture risk assessment in glucocorticoid-induced osteoporosis. Rheumatology (Oxford) 59(7):1574–1580
Confavreux CB, Chapurlat RD (2011) Systemic bone effects of biologic therapies in rheumatoid arthritis and ankylosing spondylitis. Osteoporos Int 22(4):1023–1036
pubmed: 20959960
Raterman HG, Lems WF (2019) Pharmacological management of osteoporosis in rheumatoid arthritis patients: a review of the literature and practical guide. Drugs Aging 36(12):1061–1072
pubmed: 31541358
pmcid: 6884430
Finzel S, Rech J, Schmidt S, Engelke K, Englbrecht M, Stach C et al (2011) Repair of bone erosions in rheumatoid arthritis treated with tumour necrosis factor inhibitors is based on bone apposition at the base of the erosion. Ann Rheum Dis 70(9):1587–1593
pubmed: 21622765
Finzel S, Rech J, Schmidt S, Engelke K, Englbrecht M, Schett G (2013) Interleukin-6 receptor blockade induces limited repair of bone erosions in rheumatoid arthritis: a micro CT study. Ann Rheum Dis 72(3):396–400
pubmed: 22586162
Coulson KA, Reed G, Gilliam BE, Kremer JM, Pepmueller PH (2009) Factors influencing fracture risk, T score, and management of osteoporosis in patients with rheumatoid arthritis in the Consortium of Rheumatology Researchers of North America (CORRONA) registry. J Clin Rheumatol 15(4):155–160
pubmed: 19363452
Wheater G, Elshahaly M, Naraghi K, Tuck SP, Datta HK, van Laar JM (2018) Changes in bone density and bone turnover in patients with rheumatoid arthritis treated with rituximab, results from an exploratory, prospective study. PLoS One 13(8):e0201527
pubmed: 30080871
pmcid: 6078302
Anderson J, Caplan L, Yazdany J, Robbins ML, Neogi T, Michaud K et al (2012) Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice. Arthritis Care Res (Hoboken). 64(5):640–647
pubmed: 22473918
pmcid: 4028066